Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-11-20 | New | $26,893 | $26,893 | Equity Only | 06b | SEC link |
| 2020-07-09 | New | $302,077 | $302,077 | Equity Only | 06b | SEC link |
| 2020-07-09 | New | $11,527 | $11,527 | Equity Only | 06b | SEC link |
| 2019-10-24 | New | $0 | $0 | Other | 06b | SEC link |
| 2019-10-24 | New | $0 | $0 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Shmulik Arbel | Director |
| Richard Balla | Executive |
| Vivian Bercovici | Director |
| Uri Birenberg | Executive |
| Rafael Gabay | Director |
| Amir Goldstein | Executive |
| Yael Harrosh | Executive |
| Jesse Kaplan | Director |
| Marc Lustig | Director |
| Moti Marcus | Director |
| Steven Mintz | Director |
| Michal Lebovitz Nissimov | Executive |
| Brian Schinderle | Director |
| Shai Shemesh | Executive |
| Oren Shuster | Director, Executive |
| Einat Zakariya | Director |